rawfin.tv
Vir Biotechnology Reports Q2 2026 Earnings Beat
EarningsstocksAI Generated

Vir Biotechnology Reports Q2 2026 Earnings Beat

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

Vir Biotechnology (VIR) announced strong Q2 2026 earnings, surpassing Wall Street estimates. The company reported $238.9 million in revenue, exceeding expectations.

VIREarnings BeatBiotechnologyQ2 Earnings

Related Articles

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

stocks
EQT to Acquire Cleanaway Waste for $6.5 Billion

EQT to Acquire Cleanaway Waste for $6.5 Billion

stocks
S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

stocks
US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

stocks